These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24527997)

  • 1. Model-based clinical drug development in the past, present and future: a commentary.
    Kimko H; Pinheiro J
    Br J Clin Pharmacol; 2015 Jan; 79(1):108-16. PubMed ID: 24527997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concepts and challenges in quantitative pharmacology and model-based drug development.
    Zhang L; Pfister M; Meibohm B
    AAPS J; 2008 Dec; 10(4):552-9. PubMed ID: 19003542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model-based drug development survey finds pharmacometrics impacting decision making in the pharmaceutical industry.
    Stone JA; Banfield C; Pfister M; Tannenbaum S; Allerheiligen S; Wetherington JD; Krishna R; Grasela DM
    J Clin Pharmacol; 2010 Sep; 50(9 Suppl):20S-30S. PubMed ID: 20881214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model-based drug development: strengths, weaknesses, opportunities, and threats for broad application of pharmacometrics in drug development.
    Wetherington JD; Pfister M; Banfield C; Stone JA; Krishna R; Allerheiligen S; Grasela DM
    J Clin Pharmacol; 2010 Sep; 50(9 Suppl):31S-46S. PubMed ID: 20881215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development.
    Gieschke R; Steimer JL
    Eur J Drug Metab Pharmacokinet; 2000; 25(1):49-58. PubMed ID: 11032091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fostering culture and optimizing organizational structure for implementing model-based drug development.
    Zhang L; Allerheiligen SR; Lalonde RL; Stanski DR; Pfister M
    J Clin Pharmacol; 2010 Sep; 50(9 Suppl):146S-150S. PubMed ID: 20881228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacokinetic/pharmacodynamic modeling and simulation in the pharmaceutical industry: an IQ consortium survey examining the current landscape.
    Schuck E; Bohnert T; Chakravarty A; Damian-Iordache V; Gibson C; Hsu CP; Heimbach T; Krishnatry AS; Liederer BM; Lin J; Maurer T; Mettetal JT; Mudra DR; Nijsen MJ; Raybon J; Schroeder P; Schuck V; Suryawanshi S; Su Y; Trapa P; Tsai A; Vakilynejad M; Wang S; Wong H
    AAPS J; 2015 Mar; 17(2):462-73. PubMed ID: 25630504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organs-on-chips at the frontiers of drug discovery.
    Esch EW; Bahinski A; Huh D
    Nat Rev Drug Discov; 2015 Apr; 14(4):248-60. PubMed ID: 25792263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probabilistic risk analysis: improving early drug development decision making.
    Mudd PN; Groenendaal H; Bush MA; Schmith VD
    Clin Pharmacol Ther; 2010 Dec; 88(6):871-5. PubMed ID: 20944562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry.
    Cottens S; Eaton M; Fuhr J; Geary S; Johnson DS; Li G; Raveglia L; Robertson GM; Westwell A
    Future Med Chem; 2011 Nov; 3(15):1863-72. PubMed ID: 22023030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmaceutical sciences in 2020: report of a conference organized by the board of pharmaceutical sciences of the International Pharmaceutical Federation (FIP).
    Shah VP; Besancon LJ; Stolk P; Tucker G; Crommelin DJ
    Pharm Res; 2010 Mar; 27(3):396-9. PubMed ID: 20107875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiscale modeling in drug discovery and development: future opportunities and present challenges.
    Vicini P
    Clin Pharmacol Ther; 2010 Jul; 88(1):126-9. PubMed ID: 20520608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical Decision Making With Higher Order Structure Data: Perspectives on Higher Order Structure Characterization From the Biopharmaceutical Industry.
    Weiss WF; Gabrielson JP; Al-Azzam W; Chen G; Davis DL; Das TK; Hayes DB; Houde D; Singh SK
    J Pharm Sci; 2016 Dec; 105(12):3465-3470. PubMed ID: 27743675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey on IVIVC/IVIVR development in the pharmaceutical industry - Past experience and current perspectives.
    Nguyen MA; Flanagan T; Brewster M; Kesisoglou F; Beato S; Biewenga J; Crison J; Holm R; Li R; Mannaert E; McAllister M; Mueller-Zsigmondy M; Muenster U; Ojala K; Page S; Parr A; Rossenu S; Timmins P; Van Peer A; Vermeulen A; Langguth P
    Eur J Pharm Sci; 2017 May; 102():1-13. PubMed ID: 28235611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment-based lead discovery: challenges and opportunities.
    Sun C; Petros AM; Hajduk PJ
    J Comput Aided Mol Des; 2011 Jul; 25(7):607-10. PubMed ID: 21732249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Academia and industry: allocating credit for discovery and development of new therapies.
    Flier JS
    J Clin Invest; 2019 May; 129(6):2172-2174. PubMed ID: 31107243
    [No Abstract]   [Full Text] [Related]  

  • 17. [Open innovation for Japanese pharmaceutical companies].
    Hoshino T
    Nihon Yakurigaku Zasshi; 2013 Oct; 142(4):184-9. PubMed ID: 24107523
    [No Abstract]   [Full Text] [Related]  

  • 18. Advancing drug discovery: a pharmaceutics perspective.
    Kwong E
    J Pharm Sci; 2015 Mar; 104(3):865-71. PubMed ID: 25482223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model-based drug development: a rational approach to efficiently accelerate drug development.
    Milligan PA; Brown MJ; Marchant B; Martin SW; van der Graaf PH; Benson N; Nucci G; Nichols DJ; Boyd RA; Mandema JW; Krishnaswami S; Zwillich S; Gruben D; Anziano RJ; Stock TC; Lalonde RL
    Clin Pharmacol Ther; 2013 Jun; 93(6):502-14. PubMed ID: 23588322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affairs of the Heart: Innovation in Cardiovascular Research and Development.
    Honig P; Terzic A
    Clin Pharmacol Ther; 2017 Aug; 102(2):162-168. PubMed ID: 28718903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.